The Hindu·2 min read·medium
Sun Pharma Q1 net rises 27% to ₹2,895 crore
T
The Hindu Bureau
✦AI Summary
Sun Pharmaceuticals reported a 27% increase in net profit to ₹2,895 crore for the first quarter of fiscal year 2026-27. Growth was driven by strong performance in the Indian market and the global innovative medicines segment.
Sun Pharmaceuticals Industries Ltd. for the first quarter ended June 30, 2026 reported a 27% year-n-year growth in consolidated net profit to ₹2,895 crore.
businesshealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in